MINAPHARM Pharmaceuticals (EGX:MIPH)

Egypt · Delayed Price · Currency is EGP

794.00

+0.12 (0.02%)

At close: Aug 5, 2026

232.09% (1Y)

Market Cap	9.35B +233.6%
Revenue (ttm)	6.44B +15.0%
Net Income	6.62M -74.4%
EPS	0.60 -94.8%
Shares Out	11.78M
PE Ratio	1,413.70
Forward PE	n/a
Dividend	2.50 (0.31%)
Ex-Dividend Date	Aug 12, 2026

Volume	2,035
Open	793.88
Previous Close	793.88
Day's Range	772.01 - 805.00
52-Week Range	230.00 - 831.00
Beta	0.30
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About MINAPHARM Pharmaceuticals

MINAPHARM Pharmaceuticals produces medicines, chemicals, cosmetics, veterinary medical products, medical and dental supplies, nutritional supplements, and herbal medicines in Egypt and internationally. It operates through Bio-production, Drug production, and Other products. The company provides its products for the treatment of acne, alopecia, analgesics and anti-inflammation, atopic dermatitis, autoimmune disease, bone health, cardiovascular, cerebral insufficiency, diabetic neuropathy and retinopathy, dyslipidemia, gastroenterology and hepato... [Read more]

Industry Pharmaceutical Preparations

Founded 1958

Employees 450

Stock Exchange Egyptian Stock Exchange

Ticker Symbol MIPH

Full Company Profile

Financial Performance

In 2025, MINAPHARM Pharmaceuticals's revenue was 6.44 billion, an increase of 14.97% compared to the previous year's 5.60 billion. Earnings were 6.62 million, a decrease of -94.84%.

Financial Statements